NCT06914596 is a NA clinical trial of Emanate Perio PODS in Periodontitis (Stage 3), sponsored by McGuire Institute.

Who is sponsoring NCT06914596?

NCT06914596 is sponsored by McGuire Institute.

What drugs are being tested in NCT06914596?

Interventions in NCT06914596: Emanate Perio PODS, Emanate Perio PODS.

What condition does NCT06914596 study?

NCT06914596 studies Periodontitis (Stage 3).

Is NCT06914596 still recruiting?

NCT06914596 is currently recruiting now. Last updated 10 March 2026.

Last reviewed 2026-03-10 · How we verify

NCT06914596

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP

Recruiting now NA Last updated 10 March 2026

What this trial tests

NA trial testing Emanate Perio PODS in Periodontitis (Stage 3) in 111 participants. Currently enrolling.

Timeline

19 February 2026

Primary endpoint
30 December 2026

30 January 2027

Quick facts

Lead sponsor	McGuire Institute
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	111
Start date	19 February 2026
Primary completion	30 December 2026
Estimated completion	30 January 2027
Sites	10 locations across United States

Drugs / interventions tested

Emanate Perio PODS
Emanate Perio PODS

Conditions studied

Periodontitis (Stage 3) — all drugs for Periodontitis (Stage 3) →

Sponsor

McGuire Institute — full company profile →

Who can join

Adults 22 to 75, any sex, with Periodontitis (Stage 3). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatment after.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Periodontitis (Stage 3)

Currently open trials in the same condition.

NCT06687005 — Comparative Analysis of Gremlin-1, Syndecan-4 and IL-1 Beta Levels in Gingival Crevicular Fluid Among İndividuals With P · active not recruiting
NCT07523841 — Non-surgical Periodontitis Treatment With Aspirin and Omega-3 · NA · active not recruiting

Other McGuire Institute trials

Trials by the same sponsor.

NCT06919809 — Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery · NA · completed
NCT06447844 — OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier · NA · active not recruiting
NCT05068778 — Development of an AI App to Improve Compliance in Periodontal Maintenance Patients · unknown
NCT04614350 — Pilot Study for Healing and Safety Outcomes in Gingival Recession · Phase 4 · completed
NCT04169139 — Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Periodontitis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06914596 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McGuire Institute
Last refreshed: 10 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06914596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing